| Literature DB >> 33524049 |
Delfien Syx1, Yoshihiro Ishikawa2,3, Jan Gebauer4, Sergei P Boudko2, Brecht Guillemyn1, Tim Van Damme1, Sanne D'hondt1, Sofie Symoens1, Sheela Nampoothiri5, Douglas B Gould3,6, Ulrich Baumann4, Hans Peter Bächinger2, Fransiska Malfait1.
Abstract
Heat shock protein 47 (HSP47), encoded by the SERPINH1 gene, is a molecular chaperone essential for correct folding of collagens. We report a homozygous p.(R222S) substitution in HSP47 in a child with severe osteogenesis imperfecta leading to early demise. p.R222 is a highly conserved residue located within the collagen interacting surface of HSP47. Binding assays show a significantly reduced affinity of HSP47-R222S for type I collagen. This altered interaction leads to posttranslational overmodification of type I procollagen produced by dermal fibroblasts, with increased glycosylation and/or hydroxylation of lysine and proline residues as shown by mass spectrometry. Since we also observed a normal intracellular folding and secretion rate of type I procollagen, this overmodification cannot be explained by prolonged exposure of the procollagen molecules to the modifying hydroxyl- and glycosyltransferases, as is commonly observed in other types of OI. We found significant upregulation of several molecular chaperones and enzymes involved in procollagen modification and folding on Western blot and RT-qPCR. In addition, we showed that an imbalance in binding of HSP47-R222S to unfolded type I collagen chains in a gelatin sepharose pulldown assay results in increased binding of other chaperones and modifying enzymes. The elevated expression and binding of this molecular ensemble to type I procollagen suggests a compensatory mechanism for the aberrant binding of HSP47-R222S, eventually leading to overmodification of type I procollagen chains. Together, these results illustrate the importance of HSP47 for proper posttranslational modification and provide insights into the molecular pathomechanisms of the p.(R222S) alteration in HSP47, which leads to a severe OI phenotype.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33524049 PMCID: PMC7877763 DOI: 10.1371/journal.pgen.1009339
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917